Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Dyzantil 200mg prolonged-release tablets {equilateral_black_triangle}

Active Ingredient:
sodium valproate , valproic acid
Company:  
Aspire Pharma Ltd See contact details
ATC code: 
N03AG01
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Letters to HCPs
{arrow_left}
{arrow_right}

Important information for Healthcare Professionals

{pdf_link}

Valproate DHPC - letter for HCPs (non-dispensing) UK - May 2025

{healthcare_pro_orange} For Healthcare Professionals

Valproate DHPC aRMM cover letter for HCPs (non-dispensing) UK - May 2025 (aRMM)

{pdf_link}

Valproate DHPC - letter for pharmacists UK - May 2025

{healthcare_pro_orange} For Healthcare Professionals

Valproate DHPC aRMM cover letter for Pharmacists UK - May 2025 (aRMM)

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Aspire Pharma Ltd
Company image
Address
4 Rotherbrook Court, Bedford Road, Petersfield, Hampshire, GU32 3QG, UK
Telephone
+44 (0)1730 231148
Medical Information Direct Line
+44 (0)1730 231148
Customer Care direct line
+44 (0)1730 231148
WWW
http://www.aspirepharma.co.uk